Why Women Are Getting Left Behind When It Comes to PrEP
PrEP is a highly effective HIV prevention drug that women have been slow to adopt. Female HIV experts explore the reasons why and discuss how to turn the tide.
PrEP is a highly effective HIV prevention drug that women have been slow to adopt. Female HIV experts explore the reasons why and discuss how to turn the tide.
What will it take to alleviate America’s STI epidemic? More, say David Harvey of the National Coalition of STD Directors and Avita’s Dr. Christopher Hall.
Covered entities must constantly innovate their outreach efforts to encourage community HIV testing. Here are 12 testing event tips that move the needle.
The landscape of HIV—mired in fear, stigma, and health inequity—is deeply connected to behavioral health issues. Here’s what we can do about it.
World AIDS Day is a bittersweet reminder of those we’ve lost and our ongoing fight to #EndHIV. Experts explain why the latter is going to take some out-of-the-box thinking.
International HIV expert, podcast host, entrepreneur, and activist Michelle Sherman calls pharmacists health care’s “best-kept secret.” Here’s why.
As PrEP turns 10, advocate Jim Pickett discusses the early years and what’s coming next. “We’ve come a long way, baby. But there’s so much work to do.”